Power3 Medical Products, Inc. (OTC:PWRM)
PWRM, a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced earlier this month that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, PWRM's diagnostic test, and focused on PWRM's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, PWRM's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."
"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of PWRM, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."
"We are within striking distance of realizing an Alzheimer's clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions," added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
PWRM has filed several patent applications for its NuroPro technology that are currently pending. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. PWRM intends to publish these latest findings as well.
PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM's products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease. PWRM's products analyze proteins and their mutations to assess an individual's risk for developing disease later in life or a patient's likelihood of responding to a particular drug; assess a patient's risk of disease progression and disease recurrence; and measure a patient's exposure to drug therapy. PWRM was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. PWRM was founded in 1992 and is based in The Woodlands, Texas.
To learn more about PWRM visit: http://www.Power3Medical.com
ATMI, Inc. (Nasdaq:ATMI)
ATMI recenlty announced the appointment to its Board of Directors of George M. Scalise, who recently retired as president of the Semiconductor Industry Association (SIA).
Gene Banucci, Chairman of the Board of ATMI, said, "George is a highly respected leader in the semiconductor industry. With his intimate knowledge of semiconductor technologies, finance, and global dynamics, he has helped build the stature of the industry to what it is today. We look forward to applying his keen insights and broad perspectives to further enhance ATMI's growth prospects."
ATMI supplies various high-performance materials, materials packaging, and materials delivery systems with applications in the semiconductor, flat-panel display, and in the life sciences industries worldwide. ATMI has a strategic alliance with Enthone, Inc. ATMI was founded in 1986 and is headquartered in Danbury, Connecticut.
To learn more about ATMI visit: http://www.atmi.com
Atrinsic, Inc. (Nasdaq:ATRN)
ATRN, a leading digital advertising and entertainment network, recently announced that its interactive marketing division, Atrinsic Interactive, has been selected as the affiliate management agency for BrickHouse Security, the leading provider of security, GPS tracking and surveillance products to businesses and consumers. Included in the agreement with BrickHouse, which ranks #33 of the fastest growing companies on Internet Retailer’s Top 500 list, are ATRN’s brand protection and management services and the Atrinsic Affiliate Network. Atrinsic Interactive is one of the top 10 search marketing agencies for 2010, as ranked by Advertising Age.*
ATRN operates as a direct to consumer Internet marketing company. ATRN sells entertainment and lifestyle subscription products direct to consumers through the Internet. ATRN was formerly known as New Motion, Inc. and changed its name to Atrinsic, Inc. in June 2009. ATRN. was founded in 2005 and is headquartered in New York, New York.
To learn more about ATRN visit: http://www.atrinsic.com
ATS Corporation (Amex:ATSC)
ATSC, a leading information technology company that delivers innovative technology solutions to Government and commercial customers, recently announced it has been awarded several contracts totaling $4.9 million over a one-year period, supporting the U.S. Air Force, the Defense Technology Security Administration, and other State government and commercial accounts.
"ATSC is proud of our proven 30-year track record of providing mission critical systems development services to the Department of Defense," said ATSC Executive Vice President and Chief Operating Officer, Sidney E. Fuchs. "We are also pleased to be awarded new business contracts to support our State government and commercial clients, where ATSC will provide technology evaluation and program management support services."
ATSC, through its subsidiary, Advanced Technology Systems, Inc., provides software and systems development, systems integration, information technology infrastructure and outsourcing, information sharing, and consulting services primarily to government agencies in the United States. ATSC was founded in 1978 and is headquartered in McLean, Virginia.
To learn more about ATSC visit: http://www.atsc.com
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (OTC:PWRM). Recently, Crown Equity Holdings Inc. has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (OTC:PWRM)